中国科学院院士、美国国家科学院外籍院士、美国医学科学院院士、英国皇家学会外籍院士、德国国家科学院院士、俄罗斯科学院外籍院士等。 现任中国科学院微生物研究所学术委员会主任、病原微生物与免疫学重点实验室主任、中国生物工程学会理事长、中华医学会副会长。曾任中国科学院大学存济医学院院长、国家自然科学基金委员会副主任、中国疾控中心主任、中国科学院微生物研究所所长。 他是新冠病毒的发现者、是研发全球首个临床获批使用的新冠病毒中和抗体药物和第一个获批使用的新冠病毒重组蛋白亚单位疫苗的先锋者。主要从事病原微生物跨宿主传播、感染机制与宿主细胞免疫、抗病毒手段等研究以及公共卫生政策与全球健康策略研究，为新发突发传染病防控提供重要支撑。

Prof. George F. Gao is a member (academician) of Chinese Academy of Sciences (CAS), an international member of the U.S. National Academy of Sciences (NAS), a foreign member of the U.K. Royal Society (RS), a member of the German National Academy of Sciences Leopoldina. He is a professor of Institute of Microbiology of CAS, a professor of Chinese Center for Disease Control and Prevention, a member of WHO Science and Technology Expert Group, a member of WHO One Health High-Level Expert Panel. Gao has pioneered and made numerous significant original breakthroughs on the pathogenesis mechanisms and pathogen-host interaction of emerging infectious pathogens. His interests also include global public health and health strategy, and is an advocate of international collaboration in global public health. Gao pioneers the COVID-19 research and control with virus discovery, vaccine and therapeutic monoclonal antibody development etc.